Ankle Exoskeleton for Stroke Gait Enhancement
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Georgia Institute of Technology
- Study ID
- NCT07179627
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ankle exoskeleton — DEVICEThe ankle exoskeleton provides bilateral torque assistance at the ankle joints during common functional tasks such as level-ground walking, stair and ramp ascent, and other daily activities, thereby reducing the mechanical workload and supporting more effective community ambulation. In particular, the device is designed to address drop-foot on the paretic side by delivering bidirectional assistance, which helps improve toe clearance during swing as well as push-off during stance. As a wearable assistive device, assistance is applied only while the device is worn.
- Baseline (no ankle exoskeleton) — OTHERThe intervention will serve as a baseline where participants will be asked to perform the tasks without wearing an ankle exoskeleton.
Study Details
This work will focus on new algorithms for robotic ankle exoskeletons and testing these in human subject tests. Individuals who have previously had a stroke will walk while wearing a robotic exoskeleton on a specialized treadmill as well as during other movement tasks (e.g., overground, stairs, ramps). The study will compare the performance of the advanced algorithm with not using the device to determine the clinical benefit.
Key Dates
- Start date
- Feb 9, 2026
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Ankle exoskeleton for stroke gait assistanceThis study will be conducted on a sample population of stroke subjects (single arm). Subjects will be tested with the powered ankle exoskeleton and baseline conditions.
Primary Outcome Measure
Temporal Convolutional Network (TCN) model performance (Joint moment estimation accuracy) [ Time Frame: 1 year ]
Central Contacts
- Aaron Young, PhD404-385-5306
- Kinsey Herrin, MSPO, C/LPO
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Georgia Institute of Technology | Atlanta | Georgia | 30332 | Aaron Young, PhD |
Find similar trials in Atlanta, GA
By condition
By specialty
By research site
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama